Prognostic value of N-Acetylglucosaminidase and Kidney-injury-molecule-1 in TAVI patients with severe aortic stenosis
Biomarkers in Medicine · 2024
DOI: 10.1080/17520363.2024.2429366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomarkers in Medicine, 2024. Verfasst von Congde Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Acetylglucosaminidase, Aortic Valve Stenosis, Hepatitis A Virus Cellular Receptor 1, Peptide Fragments. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
AIM: Cardiorenal syndrome (CRS) is common in severe aortic stenosis (AS). Previous studies revealed N-Acetylglucosaminidase (NAG) and Kidney-injury-molecule-1 (KIM-1) as potential markers for CRS. The study aimed to investigate the prognostic capability of NAG, KIM-1, NT-proBNP in severe AS before TAVI. MATERIALS & METHODS: Plasma and urine samples were collected from 151 participants before TAVI. Long-term follow-up (median follow-up time 31 months) was conducted to assess all-cause mortality and a composite endpoint of mortality and congestive heart failure. RESULTS: NT-proBNP was significantly elevated in classical low-flow, low-gradient AS compared to other severe AS phenotypes (p < 0.01), unlike NAG and KIM-1 (each p = n.s.). During follow-up, 40 patients (26.5%) died, and 58 patients (38.4%) reached the composite endpoint. Elevated baseline levels of NAG and KIM-1 were associated with increased risk of all-cause mortality in Kaplan-Meier analysis, like NT-proBNP (each p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany.
- Department of Clinical Chemistry and Laboratory Medicine, University Medical Center Regensburg, Regensburg, Germany.
- Department of Cardiothoracic Surgery, University Medical Center Regensburg, Regensburg, Germany.
- Department of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.
Zitieren
APA
Xu, C., Roth, N., Heidel, C., Hubauer, U., Wallner, S., Burkhardt, R., Meindl, C., Holzamer, A., Hilker, M., Creutzenberg, M., Sossalla, S., Maier, L., Debl, K., & Jungbauer, C. (2024). Prognostic value of N-Acetylglucosaminidase and Kidney-injury-molecule-1 in TAVI patients with severe aortic stenosis. Biomarkers in Medicine. https://doi.org/10.1080/17520363.2024.2429366
Vancouver
Xu C, Roth N, Heidel C, Hubauer U, Wallner S, Burkhardt R, et al. Prognostic value of N-Acetylglucosaminidase and Kidney-injury-molecule-1 in TAVI patients with severe aortic stenosis. Biomarkers in Medicine. 2024. doi:10.1080/17520363.2024.2429366
BibTeX
@article{Xu2024,
author = {Xu, Congde and Roth, Nastasia and Heidel, Carolin and Hubauer, Ute and Wallner, Stefan and Burkhardt, Ralph and Meindl, Christine and Holzamer, Andreas and Hilker, Michael and Creutzenberg, Marcus and Sossalla, Samuel and Maier, Lars and Debl, Kurt and Jungbauer, Carsten},
title = {Prognostic value of N-Acetylglucosaminidase and Kidney-injury-molecule-1 in TAVI patients with severe aortic stenosis},
journal = {Biomarkers in Medicine},
year = {2024},
doi = {10.1080/17520363.2024.2429366}
}
EUVIMED